source
- AI researcher Kyunghyun Cho leaves Genentech to explore pharma applications at Endpoints AI DayKyunghyun Cho, a noted AI researcher, announced that he has left Genentech to pursue independent work in pharmaceutical applications of machine learning. He will discuss his new focus at Endpoints…
- MPM BioImpact adds three China-origin drug programs to K2 Therapeutics portfolioMPM BioImpact, a biotech investment firm, is intensifying its "best of both worlds" approach by bringing drug candidates that originated in China to a broader market. Over the past year its portfo…